Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
A Phase 1/2 trial evaluated temozolomide with radiation therapy, with and without the VEGF inhibitor vatalanib, in newly diagnosed glioblast…
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM [Phase 2]
Phase 2 trial evaluating radiotherapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus in first-line treatment of glioblast…
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme [Phase 3]
Phase 3 trial comparing SU-101 with procarbazine for glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy [Phase 1]
A Phase 1 trial evaluating chemotherapy and radiation with chemoprotective cells and an experimental drug to reduce chemotherapy resistance …
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1) [Phase 1]
Phase 1 study evaluating MK-4827 in combination with temozolomide to assess safety and preliminary efficacy in adults with advanced cancers,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial of prinomastat in combination with temozolomide following radiation therapy for newly diagnosed glioblastoma multiforme has co…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
The study evaluates whether FET-PET imaging can effectively monitor treatment in glioblastoma multiforme patients. Results from this complet…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery [Phase 1]
A Phase 1 trial assessing Boron Neutron Capture Therapy after surgical resection of glioblastoma multiforme has been completed.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluating Acridine Carboxamide in patients with recurrent glioblastoma multiforme has been completed.
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
This is a Phase 2 trial evaluating Verubulin in combination with Temozolomide and radiation therapy for newly diagnosed glioblastoma multifo…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas [Phase 2]
A Phase 2 trial evaluating thalidomide with temozolomide or with Camptothecin-11 (irinotecan) in gliomas has completed and results were post…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors [Phase 2]
Phase 2 clinical trial assessing safety and efficacy in patients with recurrent glioblastoma multiforme (Grade 4 malignant brain tumor) has …
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM) [Phase 2]
A Phase 2 trial evaluating bevacizumab with irinotecan or with temozolomide plus radiotherapy for glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme [Phase 2]
Phase II trial completed evaluating the radiosensitizing effect of ZARNESTRA in patients with glioblastoma multiforme.
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy [Phase 2]
A Phase 2 clinical trial update evaluating thalidomide in combination with irinotecan for glioblastoma multiforme patients who have undergon…
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme [Phase 1]
A Phase 1 trial evaluating a bispecific antibody combined with white blood cells for recurrent or refractory glioblastoma multiforme has com…
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM) [Phase 2]
A Phase 2 study of Everolimus (RAD001) in patients with recurrent glioblastoma multiforme was terminated, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating stereotactic radiosurgery and conventional radiation therapy for glioblastoma multiforme has completed with results…
-
CLINICAL_TRIALS trial_result · 2011-07-04Clinical Trial Update: IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma [Phase 1]
Phase 1 trial evaluating IL13-PE38QQR infusion after surgical resection, followed by radiation therapy with or without temozolomide, in pati…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma [Phase 1, Phase 2]
This clinical trial update reports completion of a Phase 1/2 study evaluating IL13-PE38QQR as a pre-operative therapy in patients with recur…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients [Phase 1]
A completed Phase 1 trial assessed histologic effects and safety of pre/post-operative IL13-PE38QQR in patients with recurrent resectable su…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme [Phase 3]
A Phase 3 clinical trial comparing IL13-PE38QQR against GLIADEL wafer in patients with recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors [Phase 2]
This clinical trial update describes a Phase 2 safety and efficacy study for recurrent glioblastoma multiforme, which has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [Phase 2]
This Phase 2 trial of talampanel in recurrent high-grade gliomas was terminated. No results are provided in the update.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 trial evaluating imatinib mesylate plus hydroxyurea for recurrent glioblastoma multiforme was terminated; results were posted in 201…